SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
SEC Accession No. 0000902664-23-002514
Filing Date
2023-04-06
Accepted
2023-04-06 17:24:59
Documents
8

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. p23-1227prrn14a.htm PRRN14A 226418
2 GRAPHIC image_001.jpg GRAPHIC 7315
3 GRAPHIC image_002.jpg GRAPHIC 7321
4 GRAPHIC image_007.jpg GRAPHIC 3813
5 GRAPHIC internet.jpg GRAPHIC 2025
6 GRAPHIC phone.jpg GRAPHIC 2092
7 GRAPHIC mail.jpg GRAPHIC 1851
8 GRAPHIC image_003.jpg GRAPHIC 62811
  Complete submission text file 0000902664-23-002514.txt   349161
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRRN14A | Act: 34 | File No.: 001-14027 | Film No.: 23807204
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 515 MADISON AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 9TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRRN14A